Albert Vilella, PhD.
@albertvilella
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, AI/ML in biotech //
I sometimes wondered why Germany wasn't bigger in the Next-Generation Sequencing #NGS and #Multiomics picture. And in general in the spin-outs of universities as the plot shows.
Elon Musk is yet again giving wild predictions of what his companies are going to be achieving in a few years time, but this time isn't affecting what brand the robotaxi will be, Waymo or Tesla, but rather predicting the future of medicine, or to be more precise, surgery.
This is truly a reshuffle... They must hate lots of ideas they want to pursue outside the Deepmind remit
I did not have this in my bingo card this year: "DeepMind dismantles AlphaFold team in strategy shift" #Alphafold #AI #Biotech #DeepMind
One of the companies I track in my Substack will begin trading in the stock market today: Freenome $FRNM
Concentration of the Nifty Fifty over the different decades
What will happen to #biotech stocks if the #AIBubble suddenly bursts? @stepheninnes thinks part of the money could be reallocated to biotech and other sectors
Another example of a custom-made 3D-printed 96-well magnet bead purification device, triggered by a "pipette eject" event on the OpenTrons. Essentially, if the OpenTrons is thought as a flexible pipetter, then @plasmidsaurus.bsky.social turn pipette events into other MolBio tasks.
Another interesting use of 3D printed plastic adapters, in this case to turn the OpenTrons bays into racks of Oxford @nanoporetech.com PromethION flowcells.
I saw a Youtube video by @omgenomics.com profiling the work that @plasmidsaurus.bsky.social has been doing in streamlining sample preparation for their Plasmid sequencing and RNA-seq products. Interesting to see @OpenTrons instruments *everywhere*, and how they turn operations "pipette triggers".